From: Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features
Training group
Testing group
AUC
0.917
0.856
Sensitivity (%)
75
55.6
Specificity (%)
95
88.2
Accuracy (%)
88.3
76.9
Positive predictive value (%)
71.4
Negative predictive value (%)
88.4
78.9
95% CI
0.858 ~ 0.969
0.726 ~ 0.967